Antimicrobial Peptides and their Synthetic Mimics - Investigating the Mechanism o

抗菌肽及其合成模拟物 - 研究其作用机制

• 批准号: 7382929
• 负责人: David Gidalevitz
• 金额: $ 29.29万
• 依托单位: ILLINOIS INSTITUTE OF TECHNOLOGY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7382929
• 关键词: Advanced Development; Air; Anti-Bacterial Agents; Antibiotics; Antimicrobial Resistance; Antiviral Agents; Bacteria; Binding; Biological Assay; Biological Availability; Biomimetics; California; Cell Wall; Cell membrane; Cells; Chemistry; Chicago; Cholesterol; Circular Dichroism; Class; Clinical Research; Collaborations; Communicable Diseases; Comparative Study; Cytolysis; Cytoskeleton; Data; Development; Disease; Disruption; Drug usage; Endopeptidases; Engineering; Erythrocytes; Event; Fluorescence; Funding; Gram-Negative Bacteria; Gram-Positive Bacteria; Helix (Snails); Human; Illinois; Immune; Immune system; Incidence; Institutes; Knowledge; Laboratories; Left; Lipid Bilayers; Lipids; Liquid substance; Los Angeles; Lytic; Mediating; Membrane; Membrane Lipids; Membrane Proteins; Methodology; Methods; Microscopy; Molecular; Mono-S; Multi-Drug Resistance; Mutation; N-substituted Glycines; Nature; Neutrons; Numbers; Oligonucleotides; Peptide Antibiotics; Peptide Hydrolases; Peptides; Peptoids; Pharmaceutical Preparations; Pharmacologic Substance; Phosphatidyl glycerol; Phosphatidylglycerols; Physics; Plasma Cells; Polymers; Property; Protozoa; Range; Reporting; Request for Proposals; Research; Research Personnel; Research Project Grants; Resistance; Resolution; Roentgen Rays; Role; Science; Solid; Solutions; Staging; Structure; Structure-Activity Relationship; Surface; Synchrotrons; System; Techniques; Technology; Therapeutic; Today; Universities; Vesicle; Viral; Virus; Water; Work; X ray diffraction analysis; X-Ray Diffraction; analog; antimicrobial; antimicrobial drug; antimicrobial peptide; aqueous; bacterial resistance; base; design; drug resistant bacteria; ear helix; fungus; immunogenicity; infrared spectroscopy; interest; microbicide; mimicry; monolayer; novel; novel strategies; pathogenic bacteria; receptor; self assembly; solid state; viral envelope lipids

DESCRIPTION (provided by applicant): Antimicrobial peptides (AMP) form a first line of defense of the innate immune system and have a broad spectrum of microbicidal activity against a wide range of Gram-negative and Gram-positive bacteria, fungi, protozoa, and even enveloped viruses. Recently they became a matter of increasing interest because of their excellent potential in treating diseases which cannot be cured by conventional antibiotics due to antimicrobial resistance. AMPs either induce membrane damage that is a lethal event for target bacteria or bind to several targets in the cytoplasmic region of the bacteria. All the evidence indicates that the action of the AMPs does not involve stereospecific protein-receptor recognition, since the interactions of AMPs with their targets are generally considered to be nonspecific. Therefore, the character of AMP interaction with bacterial cell wall lipids, viral envelope, or native plasma cell membrane lipids largely determine their lytic potential. As part of our study, novel planar biomimetic membranes, both at air-water and solid-liquid interface will be developed. This will allow use of highly sensitive structural experimental techniques, which cannot be employed with vesicle systems nor with real cells. Furthermore, in addition to AMP we also plan to investigate membrane interactions of their synthetic peptoid mimics (ampetoids), which have an advantage of being protease-resistant, while showing high potency and selectivity as antimicrobial agents. In this highly interdisciplinary proposal we plan to use cutting edge synchrotron X-ray scattering techniques, which together with AFM and epifluorescence studies will yield near atomic resolution of peptide-lipid interaction. These data will be used to advance the understanding of AMP and ampetoids mode of action which can be used to develop rational design strategies for AMPs and antimicrobial peptide mimics to advance development of highly potent drugs that are effective even against multidrug resistant bacteria and viruses. Specific aims of this project are: (1) Examine the modes of interaction of ampetoids and natural AMPs with lipid monolayers representing an outer leaflet of red blood cell membranes and surface layer of bacterial cell wall using synchrotron grazing incidence X-ray diffraction, X-ray reflectivity, epifluorescence microscopy, and AFM used in complementary manner. (2) Design novel fluid bilayer membranes at the air-water interface, use them to examine the interaction of AMPs and ampetoids with both leaflets of bilayer membrane. (3) Design novel cholesterol tethered bilayer lipid membranes (tBLM) with cytoskeleton component. Examine mechanism of AMPs and ampetoids interaction with these tBLMs and elucidate role of cytoskeleton in their interactions. The broader impact of the proposed research is to advance development of novel antibiotic and antiviral drugs that will be immune to bacterial and viral mutations. Antimicrobial peptides and their synthetic mimics have enormous potential with regard to bacterial resistance because they interact not only with specific membrane protein receptors, but also with the lipid matrix of cell membranes, whose lipid composition is highly unlikely to change as a result of bacterial mutation. Better understanding of antimicrobial peptides and peptoids mode of action on molecular level could enhance the design and development of potent alternatives to the conventional antibiotics and antiviral drugs used today.

描述（由申请人提供）：抗菌肽（AMP）形成先天免疫系统的第一道防线，对多种革兰氏阴性和革兰氏阳性细菌、真菌、原生动物甚至包膜病毒具有广谱杀微生物活性。近年来，由于它们在治疗由于抗菌素耐药性而不能被常规抗生素治愈的疾病方面的优异潜力，它们成为越来越受关注的问题。AMP诱导膜损伤，这是靶细菌的致死事件，或者结合细菌细胞质区域中的几个靶标。所有证据表明，AMP的作用不涉及立体特异性蛋白质-受体识别，因为AMP与其靶标的相互作用通常被认为是非特异性的。因此，AMP与细菌细胞壁脂质、病毒包膜或天然浆细胞膜脂质相互作用的特征在很大程度上决定了它们的裂解潜力。作为我们研究的一部分，新型的平面仿生膜，无论是在空气-水和固-液界面将被开发。这将允许使用高度灵敏的结构实验技术，其不能用于囊泡系统也不能用于真实的细胞。此外，除了AMP之外，我们还计划研究其合成的拟肽模拟物（ampetoids）的膜相互作用，其具有抗蛋白酶的优点，同时显示出作为抗微生物剂的高效力和选择性。在这个高度跨学科的建议中，我们计划使用尖端的同步加速器X射线散射技术，与AFM和落射荧光研究一起，将产生近原子分辨率的肽-脂质相互作用。这些数据将用于推进对AMP和Ampetoids作用模式的理解，这些作用模式可用于开发AMP和抗菌肽模拟物的合理设计策略，以推进甚至对多药耐药细菌和病毒有效的高效药物的开发。本项目的具体目标是：（1）利用同步辐射掠入射X射线衍射、X射线反射率、落射荧光显微镜和原子力显微镜，以互补的方式研究安培样物质和天然AMP与代表红细胞膜外叶和细菌细胞壁表面层的脂质单层的相互作用模式。(2)在空气-水界面上设计新型流体双层膜，用它们来研究AMP和Ampetoids与双层膜的两个小叶的相互作用。(3)设计新型胆固醇系留双层类脂膜（tBLM）。研究AMP和Ampetoids与这些tBLM相互作用的机制，并阐明细胞骨架在其相互作用中的作用。拟议研究的更广泛影响是促进新型抗生素和抗病毒药物的开发，这些药物将对细菌和病毒突变免疫。抗菌肽及其合成模拟物在细菌耐药性方面具有巨大的潜力，因为它们不仅与特定的膜蛋白受体相互作用，而且与细胞膜的脂质基质相互作用，其脂质组成极不可能由于细菌突变而改变。更好地了解抗菌肽和类肽在分子水平上的作用模式，可以促进当今使用的常规抗生素和抗病毒药物的有效替代品的设计和开发。